Peer Review History

Original SubmissionJuly 22, 2023
Decision Letter - Maher Abdelraheim Titi, Editor

PONE-D-23-21887Patient satisfaction with advanced practice physiotherapy internationally: protocol for a systematic mixed studies reviewPLOS ONE

Dear Dr. Davis,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 18 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Maher Abdelraheim Titi

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

Thanks a lot for the opportunity you have offered me to revise the fascinating protocol "Patient satisfaction with advanced physiotherapy practice internationally: protocol for a systematic mixed studies review". I thank the authors for their efforts in producing this exciting protocol. It is perfectly aligned with my area of research and expertise; thus, I am confident I can offer a valuable peer review.

As a significant strength, this manuscript aims to evaluate patient satisfaction with advanced physiotherapy practice (APP) internationally and to evaluate human and system attributes of patient satisfaction with APP. This proposal is interesting in the field and adds information to the existing evidence in the literature.

As a major weakness, the manuscript sometimes lacks details and clarity concerning methodological steps that would help improve the understanding of the manuscript. Therefore, I have suggested some strategies to improve authors' reporting and increase the quality of their work.

Overall, my peer review is a minor revision: I suggest revising the manuscript to improve the pitfalls presented. The final goal is to improve the overall clarity of the message to help the reader understand this fundamental topic. I look forward to reading the revised version of the manuscript.

Thanks again, and good luck with researching in this challenging time.

¶MINOR REVISION

#INTRODUCTION

*Background: The authors analyse the concepts of patient satisfaction and patient experience in the context of physiotherapy. Although the work they do is commendable, I believe it is appropriate to integrate some fundamental references for both concepts into the background. Among them, I suggest: patient satisfaction (doi: 10.1080/09638288.2018.1501102), patient experience (doi: 10.1093/ptj/pzac080 doi: 10.1186/s40945-020-00088-6).

#METHODS

*Tidier: Please report it in full.

*Search strategy: Please report the search strategy for each database.

*Research group details: Please report details about the authors' background. Are they pt? Have they experienced in performing mixed-method systematic reviews?

#FIGURE

*Figure 1: Please report in full the abbreviation TBC.

Reviewer #2: This is an interesting protocol on patient satisfaction with advanced practice physiotherapy. I have one major comment that would need to be addressed before publication; otherwise, I provide 12 other comments to improve your protocol and eventual paper but that can be considered as minor comments/suggestions.

Major comment

1. In your eligibility criteria you include “APP (…) have post-registration masters level specialization”, however, many studies include APP without this specialization and who instead has a bachelor level education with an onsite APP training such as a residency type training. Other studies poorly described the training of APP, sometimes because many APP with different training are included. Therefore, this inclusion criterion, if taken by its words, would lead to significant number of relevant papers to be excluded from your analysis. It is also important to make the distinction between advanced practice physiotherapy roles, which does not necessarily require a specific training or highly specialized training and advanced practice physiotherapy title, that are for example not present in Canada.

Minor comments / suggestions:

1. Lines 29-30 “However, no evidence synthesis of patient satisfaction with APP across clinical fields exists.” This is no completely true as a few systematic review included a synthesis of patient satisfaction, at least of quantitative questionnaires. You also discussed results from a few studies in the introduction.

2. Lines 39-40 & 85-86 “b) have post-registration masters level specialisation” Does that mean that you will exclude all studies including advanced practice physiotherapists that do not have a masters level specialisation? If so, you will exclude some relevant studies as many include physiotherapists with a bachelor level education who received a non-master-level APP training (e.g., residency type training). Please consider removing this eligibility criteria or clarifying the text.

3. Lines 44-45: Please provide more details regarding the data synthesis plan.

4. Line 103 – Table 1: Although they were reported in the Tawiah et al. paper, are ‘Manual Therapists’, ‘Military Physician Extender’ and ‘Senior Physiotherapist Fellow’ really terms used to describe APP? I would suggest either to remove them from Table 1 or to provide a footnote providing more details (e.g., these terms have been used in the past to describe APP although …)

5. Line 105 – Table 2: in the What (procedures), we see treatment and rehabilitation that are under the scope of PT and may or may not be included in an APP model of care (although they are often included). Should a distinction be made between APP procedures (like the other ones that are described) and PT procedures that may be included in an APP model of care?

6. Line 105 – Table 2: As mentioned above, it is not necessary to be an “highly experienced, physical therapists with post-registration master’s level (or higher)” to be considered as an advanced practice physiotherapist or at least to work in an advanced practice role.

7. Lines 112-113: You discussed well the results from previous systematic reviews. However, there is two limitations in the previous systematic review that I think you should highlight. First, none of them conducted a comprehensive evaluation of patient satisfaction with APP care, instead they all focused on various outcomes specific to a clinical setting (specialized medical care or emergency department) which limit the evaluation of satisfaction to these settings. Also, they only included quantitative data, omitting to include qualitative analysis from patients interviews, for example. I think you can also cut a bit the description of these studies, especially if you are lacking word space.

8. Line 159 – Table 3: Intervention same comment as above regarding the masters level specialisation

9. Line 159 – Table 3: Study design, you could add a few examples e.g., such as experimental, observational or qualitative studies

10. Line 159 – Table 3: Which software? Also in the final article, it would be important to provide details regarding the studies that were translated and included or excluded because translation was not possible.

11. Lines 172-175: You provide the search strategy for MEDLINE and mentioned that the search strategy was adapted for other included databases. Although it is not of common practice, it would be even more transparent and useful to other researchers who might want to replicate your study to provide all search strategies in supplementary materials (at least for the paper publication).

12. Lines 280-282: You mention that a “constructivist paradigmatic approach” will be used. Although you described why you would use it, I believe that readers would benefit from having a short description of what is a “constructivist paradigmatic approach”. Also, the reference 40 (Thomas & Harden 2008) does not describe this approach.

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Simon Lafrance

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Please see attached rebuttal letter titled "response to reviewers" for our responses to all specific reviewer and editor comments.

Attachments
Attachment
Submitted filename: APP PSAT SMSR rebuttal letter PLOS ONE Sept 2023.docx
Decision Letter - Maher Abdelraheim Titi, Editor

Patient satisfaction with advanced physiotherapy practice internationally: protocol for a systematic mixed studies review

PONE-D-23-21887R1

Dear Dr. Davis,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Maher Abdelraheim Titi

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Authors,

congratulations. The paper is suitable for publication.

You have done a good job with your revision.

Best regards.

Reviewer #2: The author adequately address my comments. The description of APP in the introduction (master or equivalency) is adequate, but I believe that these details should also be present in the method section (e.g., what do you consider as an equivalence, this could be added as a footnote). A reader that reads only the method section should be able to know clearly what is included in your review. Although I believe this should be clarified, I do not think the paper should go in another revision. The authors may decide or not to make corrections.

I think there is a mistake at line 166: "They" should be "He" ?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Simon Lafrance

**********

Formally Accepted
Acceptance Letter - Maher Abdelraheim Titi, Editor

PONE-D-23-21887R1

Patient satisfaction with advanced physiotherapy practice internationally:  protocol for a systematic mixed studies review

Dear Dr. Davis:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Maher Abdelraheim Titi

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .